Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ABS-LT: A Phase 3, Long-Term, Open Label, Multicenter Safety Study of Ambrisentan in Subjects With Pulmonary Hypertension

NCT00777920 is registered in ClinicalTrials.gov with Gilead Sciences as lead sponsor.

NCT NCT00777920
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00777920 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ABS-LT: A Phase 3, Long-Term, Open Label, Multicenter Safety Study of Ambrisentan in Subjects With Pulmonary Hypertension
Lead sponsor
Gilead Sciences
Phase
Phase 3
Overall status
Completed
Start date
November 17, 2008
Completion date
September 11, 2019
Enrollment
140 (actual)
Sites
46

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary hypertension